Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nucleo CMP Forte in Pediatric Traumatic Brain Injury
NCT04499755Phase 3Recruiting
- Start
- Jun 2020
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Nucleo CMP Forte in traumatic brain injury (TBI). Started Jun 2020; status: recruiting.
02
Drugs
Nucleo CMP Forte
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT04499755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04499755.